 [2007-1-1]Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study |
| [2007-1-1]Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical Prostatectomy |
| [2007-1-1]Durable Clinical, Cytogenetic, and Molecular Remissions After Allogeneic Hematopoietic Cell Transplantation for Refractory Sezary Syndrome a |
| [2007-1-1]Outcome Analysis for Patients With Elevated Serum Tumor Markers at Postchemotherapy Retroperitoneal Lymph Node Dissection |
| [2007-1-1]Occurrence of Second Cancers in Patients Treated With Radiotherapy for Rectal Cancer |
| [2007-1-1]Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint |
| [2007-1-1]Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer |
| [2007-1-1]Associations Between Drug Metabolism Genotype, Chemotherapy Pharmacokinetics, and Overall Survival in Patients With Breast Cancer |
| [2007-1-1]Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day |
| [2007-1-1]Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part II: Immunologic Effects |
| [2007-1-1]Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological Ef |
| [2007-1-1]Survival in Patients Operated on for Pathologic Fracture: Implications for End-of-Life Orthopedic Care |
| [2007-1-1]Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation |
| [2007-1-1]Population-Based Assessment of Surgical Treatment Trends for Patients With Melanoma in the Era of Sentinel Lymph Node Biopsy |
| [2007-1-1]Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 |
| [2007-1-1]Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer? |
| [2007-1-1]Randomized Controlled Trial of an Educational Intervention for Managing Fatigue in Women Receiving Adjuvant Chemotherapy for Early-Stage Bre |
| [2007-1-1]Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer |
| [2007-1-1]Outcomes From the Moving Beyond Cancer Psychoeducational, Randomized, Controlled Trial With Breast Cancer Patients |
| [2007-1-1]Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cance |
| [2007-1-1]Prospective Multicenter Validation of the Independent Prognostic Value of the Mitotic Activity Index in Lymph Node–Negative Breast Cancer Pa |
| [2007-1-1]Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks |
| [2007-1-1]Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results F |
| [2007-1-1]Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemo |
| [2007-1-1]Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer |
| [2007-1-1]Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer |
| [2007-1-1]Prognostic Importance of Preoperative CA-125 in International Federation of Gynecology and Obstetrics Stage I Epithelial Ovarian Cancer: An |
| [2007-1-1]Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer |
| [2007-1-1]Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With |
| [2007-1-1]Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lun |
| [2007-1-1]Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung |
| [2007-1-1]TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small- |
| [2007-1-1]Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Loc |
| [2007-1-1]American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer |
| [2007-1-1]Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat |
| [2007-1-1]Dermatofibrosarcoma Protuberans Treated at a Single Institution: A Surgical Disease With a High Cure Rate |
| [2007-1-1]Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies |
| [2007-1-1]Improved Detection of Second Primary Cancer Using Integrated [18F] Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography f |
| [2007-1-1]Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma |
| [2007-1-1]Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based Study |
| [2007-1-1]Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Maki |
| [2007-1-1]Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders |
| [2007-1-1]Sustained Complete Molecular Remissions After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplan |
| [2007-1-1]The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tum |
| [2007-1-1]Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Tr |
| [2007-1-1]Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral |
| [2007-1-1]Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database St |
| [2007-1-1]Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival |
| [2007-1-1]Retrospective Analysis of Time to Recurrence in the ATAC Trial According to Hormone Receptor Status: An Hypothesis-Generating Study |
| [2007-1-1]Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors |
| [2007-1-1]Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study |
| [2007-1-1]Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly As |
| [2007-1-1]Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer |
| [2007-1-1]Ionizing Radiation and Tobacco Use Increases the Risk of a Subsequent Lung Carcinoma in Women With Breast Cancer: Case-Only Design |
| [2007-1-1]Assessing Benefit and Risk in the Prevention of Prostate Cancer: The Prostate Cancer Prevention Trial Revisited |
| [2007-1-1]Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advan |
| [2007-1-1]Feasibility of Withholding Antibiotics in Selected Febrile Neutropenic Cancer Patients |
| [2007-1-1]Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Pro |
| [2007-1-1]Quality of Life and Sexual Functioning in Cervical Cancer Survivors |
| [2007-1-1]Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer |
| [2007-1-1]Defining Cancer Patients As Being in the Terminal Phase: Who Receives a Formal Diagnosis, and What Are the Effects? |
| [2007-1-1]Posttraumatic Stress Symptoms During Treatment in Parents of Children With Cancer |
| [2007-1-1]Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy |
| [2007-1-1]Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the Nati |
| [2007-1-1]Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients |
| [2007-1-1]Molecular Classification of Multiple Myeloma: A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14 |
| [2007-1-1]Gene Expression Profile Predicts Patient Survival of Gastric Cancer After Surgical Resection |
| [2007-1-1]Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study |
| [2007-1-1]Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Canc |
| [2007-1-1]Inferring a Tumor Progression Model for Neuroblastoma From Genomic Data |
| [2007-1-1]Proliferation Marker Ki-67 in Early Breast Cancer |
| [2007-1-1]Phase I Trial of Temozolomide Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma |
| [2007-1-1]Population-Based Analysis of Prognostic Factors and Survival in Familial Melanoma |
| [2007-1-1]Long-Term Results of a Randomized Trial on Extended Use of High Dose L-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia |
| [2007-1-1]Intellectual and Functional Outcome of Children 3 Years Old or Younger Who Have CNS Malignancies |
| [2007-1-1]Late Effects of Pelvic Rhabdomyosarcoma and Its Treatment in Female Survivors |
| [2007-1-1]OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer |
| [2007-1-1]OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer |
| [2007-1-1]Impact of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: Data From a Large US-Population Database |
| [2007-1-1]Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer |
